|
US2056046A
(en)
|
1933-05-19 |
1936-09-29 |
Rhone Poulenc Sa |
Manufacture of bases derived from benz-dioxane
|
|
US2375138A
(en)
|
1942-05-01 |
1945-05-01 |
American Cyanamid Co |
Alkamine esters of aryloxymethyl benzoic acid
|
|
US2629736A
(en)
|
1951-02-24 |
1953-02-24 |
Searle & Co |
Basically substituted n-alkyl derivatives of alpha, beta, beta-triarylpropionamides
|
|
US2730544A
(en)
|
1952-07-23 |
1956-01-10 |
Sahyun Lab |
Alkylaminoalkyl esters of hydroxycyclohexylbenzoic acid
|
|
US2750387A
(en)
|
1953-11-25 |
1956-06-12 |
Searle & Co |
Basically substituted derivatives of diarylaminobenzamides
|
|
DE1211359B
(de)
|
1955-11-29 |
1966-02-24 |
Oreal |
Oxydationsmittelfreies Kaltfaerbemittel fuer menschliches Haar
|
|
US2928833A
(en)
|
1959-03-03 |
1960-03-15 |
S E Massengill Company |
Theophylline derivatives
|
|
BE610354A
(https=)
|
1960-11-16 |
|
|
|
|
US3155705A
(en)
|
1961-01-19 |
1964-11-03 |
Rohm & Haas |
Acrylates and methacrylates of bicyclic phosphites and bicyclic phosphates
|
|
US3173859A
(en)
|
1961-08-24 |
1965-03-16 |
Berks Associates Inc |
Crankcase oil refining
|
|
US3212183A
(en)
|
1962-12-28 |
1965-10-19 |
United Aircraft Corp |
Reduction of explosive joint edge degradation
|
|
US3174901A
(en)
|
1963-01-31 |
1965-03-23 |
Jan Marcel Didier Aron Samuel |
Process for the oral treatment of diabetes
|
|
US3186392A
(en)
|
1963-12-23 |
1965-06-01 |
Bran F Gregoric |
Apparatus and method for improving combustion in an internal combustion engine
|
|
US3454635A
(en)
|
1965-07-27 |
1969-07-08 |
Hoechst Ag |
Benzenesulfonyl-ureas and process for their manufacture
|
|
US3673241A
(en)
|
1968-04-04 |
1972-06-27 |
Ciba Geigy Corp |
Substituted benzaldehyde guanylhydrazones
|
|
ES385302A1
(es)
|
1970-10-22 |
1973-04-16 |
Miquel S A Lab |
Procedimiento para la obtencion de derivados trisubstitui- dos de etilendiamina.
|
|
DE2205815A1
(de)
|
1972-02-08 |
1973-08-16 |
Hoechst Ag |
Piperazinderivate und verfahren zu ihrer herstellung
|
|
JPS5512435B2
(https=)
|
1972-07-01 |
1980-04-02 |
|
|
|
US4005208A
(en)
|
1975-05-16 |
1977-01-25 |
Smithkline Corporation |
N-Heterocyclic-9-xanthenylamines
|
|
US4061753A
(en)
|
1976-02-06 |
1977-12-06 |
Interx Research Corporation |
Treating psoriasis with transient pro-drug forms of xanthine derivatives
|
|
DE2758025A1
(de)
|
1977-12-24 |
1979-07-12 |
Bayer Ag |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
|
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
DE2929596A1
(de)
|
1979-07-21 |
1981-02-05 |
Hoechst Ag |
Verfahren zur herstellung von oxoalkyl-xanthinen
|
|
CY1306A
(en)
|
1980-10-01 |
1985-12-06 |
Glaxo Group Ltd |
Aminoalkyl furan derivative
|
|
US4382091A
(en)
|
1981-04-30 |
1983-05-03 |
Syntex (U.S.A.) Inc. |
Stabilization of 1-substituted imidazole derivatives in talc
|
|
FR2558162B1
(fr)
|
1984-01-17 |
1986-04-25 |
Adir |
Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
|
|
FI79107C
(fi)
|
1984-06-25 |
1989-11-10 |
Orion Yhtymae Oy |
Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
|
|
JPS6130567A
(ja)
|
1984-07-23 |
1986-02-12 |
Shiseido Co Ltd |
尿素の安定化法
|
|
JPS61124383A
(ja)
|
1984-11-16 |
1986-06-12 |
Unitika Ltd |
固定化線維素溶解活性酵素の安定化法
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
CA1242699A
(en)
|
1985-02-01 |
1988-10-04 |
Bristol-Myers Company |
Cefbuperazone and derivatives thereof
|
|
US4741898A
(en)
|
1985-04-01 |
1988-05-03 |
Fisher Scientific Company |
Stabilized stain composition
|
|
GB8515934D0
(en)
|
1985-06-24 |
1985-07-24 |
Janssen Pharmaceutica Nv |
(4-piperidinomethyl and-hetero)purines
|
|
US5258380A
(en)
|
1985-06-24 |
1993-11-02 |
Janssen Pharmaceutica N.V. |
(4-piperidinylmethyl and -hetero)purines
|
|
EP0223403B1
(en)
|
1985-10-25 |
1993-08-04 |
Beecham Group Plc |
Piperidine derivative, its preparation, and its use as medicament
|
|
US5034225A
(en)
|
1985-12-17 |
1991-07-23 |
Genentech Inc. |
Stabilized human tissue plasminogen activator compositions
|
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
|
EP0237608B1
(de)
|
1986-03-21 |
1992-01-29 |
HEUMANN PHARMA GMBH & CO |
Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
JP2583257B2
(ja)
|
1986-05-05 |
1997-02-19 |
ザ・ジェネラル・ホスピタル・コーポレーション |
インシュリン向性ホルモン
|
|
AU619444B2
(en)
|
1986-06-02 |
1992-01-30 |
Nippon Chemiphar Co. Ltd. |
2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
|
|
US4968672A
(en)
|
1987-01-02 |
1990-11-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenosine receptor prodrugs
|
|
US4743450A
(en)
|
1987-02-24 |
1988-05-10 |
Warner-Lambert Company |
Stabilized compositions
|
|
JPS6440433A
(en)
|
1987-08-05 |
1989-02-10 |
Green Cross Corp |
Aqueous liquid composition of thrombin
|
|
CA1340285C
(en)
|
1988-05-19 |
1998-12-22 |
Hiroyuki Nagano |
Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent
|
|
US5329025A
(en)
|
1988-09-21 |
1994-07-12 |
G. D. Searle & Co. |
3-azido compound
|
|
DE3926119A1
(de)
|
1989-08-08 |
1991-02-14 |
Bayer Ag |
3-amino-5-aminocarbonyl-1,2,4-triazol-derivate
|
|
US5234897A
(en)
|
1989-03-15 |
1993-08-10 |
Bayer Aktiengesellschaft |
Herbicidal 3-amino-5-aminocarbonyl-1,2,4-triazoles
|
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
|
DE3916430A1
(de)
|
1989-05-20 |
1990-11-22 |
Bayer Ag |
Verfahren zur herstellung von 3-amino-5-aminocarbonyl-1,2,4-triazol-derivaten
|
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
|
US5223499A
(en)
|
1989-05-30 |
1993-06-29 |
Merck & Co., Inc. |
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
|
|
US5332744A
(en)
|
1989-05-30 |
1994-07-26 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
|
HU208115B
(en)
|
1989-10-03 |
1993-08-30 |
Biochemie Gmbh |
New process for producting pleuromutilin derivatives
|
|
FR2654935B1
(fr)
|
1989-11-28 |
1994-07-01 |
Lvmh Rech |
Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux.
|
|
DE122007000050I1
(de)
|
1990-02-19 |
2007-11-08 |
Novartis Ag |
Acylverbindungen
|
|
KR930000861B1
(ko)
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
|
EP0475482B1
(en)
|
1990-09-13 |
1994-10-05 |
Akzo Nobel N.V. |
Stabilized solid chemical compositions
|
|
GB9020959D0
(en)
|
1990-09-26 |
1990-11-07 |
Beecham Group Plc |
Novel compounds
|
|
US5084460A
(en)
|
1990-12-24 |
1992-01-28 |
A. H. Robins Company, Incorporated |
Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
|
|
US5591762A
(en)
|
1991-02-06 |
1997-01-07 |
Dr. Karl Thomae Gmbh |
Benzimidazoles useful as angiotensin-11 antagonists
|
|
US5594003A
(en)
|
1991-02-06 |
1997-01-14 |
Dr. Karl Thomae Gmbh |
Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
|
US5602127A
(en)
|
1991-02-06 |
1997-02-11 |
Karl Thomae Gmbh |
(Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
|
GB9109862D0
(en)
|
1991-05-08 |
1991-07-03 |
Beecham Lab Sa |
Pharmaceutical formulations
|
|
DE4124150A1
(de)
|
1991-07-20 |
1993-01-21 |
Bayer Ag |
Substituierte triazole
|
|
US5300298A
(en)
|
1992-05-06 |
1994-04-05 |
The Pennsylvania Research Corporation |
Methods of treating obesity with purine related compounds
|
|
GB9215633D0
(en)
|
1992-07-23 |
1992-09-09 |
Smithkline Beecham Plc |
Novel treatment
|
|
EP0581552B1
(en)
|
1992-07-31 |
1998-04-22 |
Shionogi & Co., Ltd. |
Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same
|
|
TW252044B
(https=)
|
1992-08-10 |
1995-07-21 |
Boehringer Ingelheim Kg |
|
|
DE4242459A1
(de)
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
Imidazopyridine
|
|
US5624926A
(en)
|
1993-02-18 |
1997-04-29 |
Kyowa Hakko Kogyo Co., Ltd. |
Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
|
|
JP3726291B2
(ja)
|
1993-07-05 |
2005-12-14 |
三菱ウェルファーマ株式会社 |
安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
|
|
FR2707641B1
(fr)
|
1993-07-16 |
1995-08-25 |
Fournier Ind & Sante |
Composés de l'imidazol-5-carboxamide, leur procédé de préparation leurs intermédiaires et leur utilisation en thérapeutique.
|
|
DE4339868A1
(de)
|
1993-11-23 |
1995-05-24 |
Merck Patent Gmbh |
Imidazopyridazine
|
|
DE4404183A1
(de)
|
1994-02-10 |
1995-08-17 |
Merck Patent Gmbh |
4-Amino-1-piperidylbenzoylguanidine
|
|
US5545745A
(en)
|
1994-05-23 |
1996-08-13 |
Sepracor, Inc. |
Enantioselective preparation of optically pure albuterol
|
|
CO4410190A1
(es)
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
|
|
AU699489B2
(en)
|
1994-10-12 |
1998-12-03 |
Euro-Celtique S.A. |
Novel benzoxazoles
|
|
GB9501178D0
(en)
|
1995-01-20 |
1995-03-08 |
Wellcome Found |
Guanine derivative
|
|
AU692104B2
(en)
|
1995-05-19 |
1998-05-28 |
Darwin Discovery Limited |
Xanthines and their therapeutic use
|
|
JPH08333339A
(ja)
|
1995-06-08 |
1996-12-17 |
Fujisawa Pharmaceut Co Ltd |
光学活性なピペリジン酢酸誘導体の製造法
|
|
GB9523752D0
(en)
|
1995-11-21 |
1996-01-24 |
Pfizer Ltd |
Pharmaceutical formulations
|
|
DE19543478A1
(de)
|
1995-11-22 |
1997-05-28 |
Bayer Ag |
Kristallines Hydrochlorid von {(R)-(-)-2- N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-buytl]-aminomethyl}-chroman
|
|
WO1999029695A1
(en)
|
1997-12-05 |
1999-06-17 |
Astrazeneca Uk Limited |
Novel compounds
|
|
FR2742751B1
(fr)
|
1995-12-22 |
1998-01-30 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
NZ326238A
(en)
|
1995-12-26 |
1999-11-29 |
Alteon Inc |
Compositons and methods for inhibiting nonenzymatic cross-linking and glycosylation (protein aging) using N-acylaminoalkylhydrazine carboximidamides
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW518219B
(en)
|
1996-04-26 |
2003-01-21 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
|
WO1997046526A1
(en)
|
1996-06-07 |
1997-12-11 |
Eisai Co., Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
|
|
US5965555A
(en)
|
1996-06-07 |
1999-10-12 |
Hoechst Aktiengesellschaft |
Xanthine compounds having terminally animated alkynol side chains
|
|
US5958951A
(en)
|
1996-06-14 |
1999-09-28 |
Novo Nordiskials |
Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
|
|
US5753635A
(en)
|
1996-08-16 |
1998-05-19 |
Berlex Laboratories, Inc. |
Purine derivatives and their use as anti-coagulants
|
|
JP2001500878A
(ja)
|
1996-09-23 |
2001-01-23 |
イーライ・リリー・アンド・カンパニー |
オランザピン二水和物ｄ
|
|
WO1998018770A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
DE69732572T2
(de)
|
1996-11-12 |
2005-12-29 |
Novo Nordisk A/S |
Verwendung von glp-1 peptiden
|
|
GB9623859D0
(en)
|
1996-11-15 |
1997-01-08 |
Chiroscience Ltd |
Novel compounds
|
|
TR199901968T2
(xx)
|
1996-12-24 |
1999-12-21 |
Biogen, Inc. |
Sabit s�v� interferon form�lleri.
|
|
DE19705233A1
(de)
|
1997-02-12 |
1998-08-13 |
Froelich Juergen C |
Verfahren zur Herstellung einer Formulierung enthaltend Arginin
|
|
US6011049A
(en)
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
|
IL131651A0
(en)
|
1997-03-13 |
2001-01-28 |
Hexal Ag |
A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
|
|
US5972332A
(en)
|
1997-04-16 |
1999-10-26 |
The Regents Of The University Of Michigan |
Wound treatment with keratinocytes on a solid support enclosed in a porous material
|
|
JPH11895A
(ja)
|
1997-06-10 |
1999-01-06 |
Nichiha Corp |
板材搬送コンベア及び該搬送コンベアを持つ子割セメント板の製造装置
|
|
AR012894A1
(es)
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
|
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
|
ID21411A
(id)
|
1997-12-10 |
1999-06-10 |
Takeda Chemical Industries Ltd |
Agen untuk mengobati daya tahan glukosa yang berisiko tinggi rusak
|
|
JPH11193270A
(ja)
|
1997-12-26 |
1999-07-21 |
Koei Chem Co Ltd |
光学活性１−メチル−３−ピペリジンメタノールの製造方法
|
|
AU1688599A
(en)
|
1998-01-05 |
1999-07-26 |
Eisai Co. Ltd. |
Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
|
|
EP2583675A1
(en)
|
1998-02-02 |
2013-04-24 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
|
SK14742000A3
(sk)
|
1998-03-31 |
2001-03-12 |
Nissan Chemical Industries, Ltd. |
Pyridazinónová hydrochloridová zlúčenina a spôsob jej prípravy
|
|
CA2268621A1
(en)
|
1998-04-13 |
1999-10-13 |
Takeda Chemical Industries, Ltd. |
2-pipirazinone-1-acetic acid derivative, production and use thereof
|
|
US6207207B1
(en)
|
1998-05-01 |
2001-03-27 |
Mars, Incorporated |
Coated confectionery having a crispy starch based center and method of preparation
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
CA2337015C
(en)
|
1998-07-15 |
2004-09-07 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Excipient
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
IT1312018B1
(it)
|
1999-03-19 |
2002-04-04 |
Fassi Aldo |
Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina.
|
|
US20040152659A1
(en)
|
1999-05-12 |
2004-08-05 |
Fujisawa Pharmaceutical Co. Ltd. |
Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
|
|
AU4431000A
(en)
|
1999-05-12 |
2000-12-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel use
|
|
WO2000072799A2
(en)
|
1999-05-27 |
2000-12-07 |
The University Of Virginia Patent Foundation |
Method and compositions for treating the inflammatory response
|
|
CN100448482C
(zh)
|
1999-05-31 |
2009-01-07 |
三菱化学株式会社 |
Hgf冻干制剂
|
|
AU5300000A
(en)
|
1999-06-01 |
2000-12-18 |
Elan Pharma International Limited |
Small-scale mill and method thereof
|
|
US6545002B1
(en)
|
1999-06-01 |
2003-04-08 |
University Of Virginia Patent Foundation |
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
|
HK1044769B
(zh)
|
1999-06-21 |
2005-02-25 |
贝林格尔英格海姆法玛两合公司 |
雙環雜環化合物，含有該化合物的藥物組合物，該化合物的用途及其製備方法
|
|
US6448323B1
(en)
|
1999-07-09 |
2002-09-10 |
Bpsi Holdings, Inc. |
Film coatings and film coating compositions based on polyvinyl alcohol
|
|
ES2166270B1
(es)
|
1999-07-27 |
2003-04-01 |
Almirall Prodesfarma Sa |
Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
HUP0600522A2
(en)
|
1999-12-23 |
2006-11-28 |
Novartis Ag |
Use of hypoglycemic agent for treating impaired glucose metabolism
|
|
EP1248869A2
(en)
|
2000-01-07 |
2002-10-16 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6362172B2
(en)
|
2000-01-20 |
2002-03-26 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
|
EP1743655B1
(en)
|
2000-01-21 |
2014-06-25 |
Novartis AG |
Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
|
|
JP4621326B2
(ja)
|
2000-02-01 |
2011-01-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
テプレノンの安定化組成物
|
|
JP4739632B2
(ja)
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｅｒｋのインヒビターとして有用なピラゾール組成物
|
|
WO2001062295A1
(en)
|
2000-02-24 |
2001-08-30 |
Takeda Chemical Industries, Ltd. |
Drugs containing combined active ingredients
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
GB0006133D0
(en)
|
2000-03-14 |
2000-05-03 |
Smithkline Beecham Plc |
Novel pharmaceutical
|
|
JP2001278812A
(ja)
|
2000-03-27 |
2001-10-10 |
Kyoto Pharmaceutical Industries Ltd |
錠剤用崩壊剤及びこれを用いた錠剤
|
|
US7282219B2
(en)
|
2000-03-31 |
2007-10-16 |
Kirin Beer Kabushiki Kaisha |
Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
|
|
KR20080067009A
(ko)
|
2000-03-31 |
2008-07-17 |
프로시디온 리미티드 |
디펩티딜 펩티다제 ⅳ 효소 활성 억제제를 포함하는약제학적 조성물
|
|
JP2001292388A
(ja)
|
2000-04-05 |
2001-10-19 |
Sharp Corp |
再生装置
|
|
GB0008694D0
(en)
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
|
WO2001096301A1
(en)
|
2000-06-14 |
2001-12-20 |
Toray Industries, Inc. |
Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
US6689353B1
(en)
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
|
AU2001268958B2
(en)
|
2000-07-04 |
2006-03-09 |
Novo Nordisk A/S |
Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
|
|
JP4101053B2
(ja)
|
2000-08-10 |
2008-06-11 |
田辺三菱製薬株式会社 |
プロリン誘導体及びその医薬用途
|
|
MY133943A
(en)
*
|
2000-08-22 |
2007-11-30 |
Synthes Gmbh |
Bone replacement material
|
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
|
US20060034922A1
(en)
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
CA2433090A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
FR2818906B1
(fr)
|
2000-12-29 |
2004-04-02 |
Dospharma |
Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
|
|
FR2819254B1
(fr)
|
2001-01-08 |
2003-04-18 |
Fournier Lab Sa |
Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques
|
|
DE10109021A1
(de)
|
2001-02-24 |
2002-09-05 |
Boehringer Ingelheim Pharma |
Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10117803A1
(de)
|
2001-04-10 |
2002-10-24 |
Boehringer Ingelheim Pharma |
Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
SK10802003A3
(sk)
|
2001-02-02 |
2004-05-04 |
Takeda Chemical Industries, Ltd. |
Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok
|
|
WO2002066015A1
(en)
|
2001-02-16 |
2002-08-29 |
Bristol-Myers Squibb Pharma Company |
Use of polyalkylamine polymers in controlled release devices
|
|
EP1368349B1
(de)
|
2001-02-24 |
2007-02-14 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
|
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
US6693094B2
(en)
|
2001-03-22 |
2004-02-17 |
Chrono Rx Llc |
Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
|
|
JP2002348279A
(ja)
|
2001-05-25 |
2002-12-04 |
Nippon Kayaku Co Ltd |
光学活性ピリジルケトン誘導体の製造方法並びに光学活性ピリジルケトン誘導体
|
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
CN1723196A
(zh)
|
2001-06-27 |
2006-01-18 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
|
JP4357293B2
(ja)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
DE60225556D1
(de)
|
2001-07-03 |
2008-04-24 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
WO2003006424A1
(en)
|
2001-07-10 |
2003-01-23 |
4Sc Ag |
Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
US7638522B2
(en)
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
|
AU2002331311A1
(en)
|
2001-09-19 |
2003-04-01 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
JP2005514008A
(ja)
|
2001-09-24 |
2005-05-19 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
摂食行動を改変する薬剤をスクリーニングするための、弓状核におけるニューロンの評価方法
|
|
CN1568166A
(zh)
|
2001-10-15 |
2005-01-19 |
荷姆泰克股份有限公司 |
预防再狭窄的涂层支架
|
|
DE10151296A1
(de)
|
2001-10-17 |
2003-04-30 |
Boehringer Ingelheim Pharma |
Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
US20030083354A1
(en)
|
2001-10-26 |
2003-05-01 |
Pediamed Pharmaceuticals, Inc. |
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
|
|
CA2363053C
(en)
|
2001-11-09 |
2011-01-25 |
Bernard Charles Sherman |
Clopidogrel bisulfate tablet formulation
|
|
WO2003045228A2
(en)
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Methods for treating autoimmune disorders, and reagents related thereto
|
|
US20040171836A1
(en)
|
2001-12-21 |
2004-09-02 |
Toshihiro Fujino |
Method for producing optical-active cis-piperidine derivatives
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
JP3668241B2
(ja)
|
2001-12-28 |
2005-07-06 |
株式会社Ｎｒｌファーマ |
脂質代謝改善用組成物
|
|
EP1474163A2
(en)
|
2002-01-10 |
2004-11-10 |
Imperial College Innovations Limited |
Modification of feeding behavior
|
|
AU2003201274A1
(en)
|
2002-01-11 |
2003-07-24 |
Novo Nordisk A/S |
Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes
|
|
US20070197552A1
(en)
*
|
2002-01-11 |
2007-08-23 |
Novo Nordisk A/S |
Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
|
|
BR0215514A
(pt)
|
2002-01-16 |
2004-12-21 |
Boehringer Ingelheim Pharma |
Comprimido farmacêutico de bicamada compreendendo telmisartan e um diurético e preparação deste
|
|
WO2003061688A1
(en)
|
2002-01-21 |
2003-07-31 |
Nrl Pharma, Inc. |
Novel analgesics
|
|
EP1333033A1
(en)
|
2002-01-30 |
2003-08-06 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
FAP-activated anti-tumor compounds
|
|
WO2003063831A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Immediate release dosage forms containing solid drug dispersions
|
|
US7610153B2
(en)
|
2002-02-13 |
2009-10-27 |
Virginia Commonwealth University |
Multi-drug titration and evaluation
|
|
MXPA04008100A
(es)
|
2002-02-21 |
2005-06-17 |
Biovail Lab Int Srl |
Formulaciones de liberacion modificada de al menos una forma de tramadol.
|
|
EP1338595B1
(en)
|
2002-02-25 |
2006-05-03 |
Eisai Co., Ltd. |
Xanthine derivatives as DPP-IV inhibitors
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
JP4298212B2
(ja)
|
2002-03-29 |
2009-07-15 |
大日本印刷株式会社 |
塩酸エピナスチン高融点型結晶の製造法
|
|
JP2003300977A
(ja)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
キサンチン誘導体
|
|
EP1496982A4
(en)
|
2002-04-16 |
2006-07-19 |
Merck & Co Inc |
SOLID FORMS OF SALTS WITH TYROSINE KINASE EFFECT
|
|
CA2484306A1
(en)
|
2002-04-26 |
2003-11-06 |
Katsumi Maezono |
Prophylactic and therapeutic agent of diabetes mellitus
|
|
AU2003231252A1
(en)
|
2002-05-09 |
2003-11-11 |
Enos Pharmaceuticals, Inc. |
Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
DE60307628T2
(de)
|
2002-05-31 |
2007-08-09 |
Schering Corporation |
Verfahren zur herstellung von xanthin phosphodiesterase v inhibitoren und deren vorstufen
|
|
AU2003241960B2
(en)
|
2002-06-06 |
2009-07-30 |
Eisai R&D Management Co., Ltd. |
Novel fused imidazole derivative
|
|
ES2199061B1
(es)
|
2002-06-10 |
2005-02-16 |
Laboratorios Vita, S.A. |
Comprimidos bucodispersables y procedimiento para su obtencion.
|
|
FR2840897B1
(fr)
|
2002-06-14 |
2004-09-10 |
Fournier Lab Sa |
Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
|
|
US20040002615A1
(en)
|
2002-06-28 |
2004-01-01 |
Allen David Robert |
Preparation of chiral amino-nitriles
|
|
US20040023981A1
(en)
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Salt forms with tyrosine kinase activity
|
|
AR040661A1
(es)
|
2002-07-26 |
2005-04-13 |
Theravance Inc |
Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
|
|
TW200404796A
(en)
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
|
ES2339112T3
(es)
|
2002-08-21 |
2010-05-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
8-(3-amino-piperidin-1-il)-xantinas,su preparacion y su uso como medicamentos.
|
|
DE10238243A1
(de)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
AU2003262059A1
(en)
|
2002-09-11 |
2004-04-30 |
Takeda Pharmaceutical Company Limited |
Sustained release preparation
|
|
WO2004024125A1
(en)
|
2002-09-16 |
2004-03-25 |
Wyeth |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
|
|
MXPA05003252A
(es)
|
2002-09-26 |
2005-07-05 |
Eisai Co Ltd |
Farmaco de combinacion.
|
|
CN1720025A
(zh)
|
2002-10-08 |
2006-01-11 |
兰贝克赛实验室有限公司 |
加巴喷丁片剂及其制备
|
|
AU2003269850A1
(en)
|
2002-10-08 |
2004-05-04 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
|
US20040122048A1
(en)
|
2002-10-11 |
2004-06-24 |
Wyeth Holdings Corporation |
Stabilized pharmaceutical composition containing basic excipients
|
|
US6861526B2
(en)
|
2002-10-16 |
2005-03-01 |
Pfizer Inc. |
Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
|
|
CA2502269C
(en)
|
2002-10-18 |
2009-12-22 |
Merck & Co., Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
JP2004161749A
(ja)
|
2002-10-24 |
2004-06-10 |
Toray Fine Chemicals Co Ltd |
光学活性含窒素化合物の製造方法
|
|
AU2003280680A1
(en)
|
2002-11-01 |
2004-06-18 |
Sumitomo Pharmaceuticals Co., Ltd. |
Xanthine compound
|
|
CA2504735C
(en)
|
2002-11-07 |
2009-06-23 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
AU2002952946A0
(en)
*
|
2002-11-27 |
2002-12-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
ATE404191T1
(de)
|
2002-12-10 |
2008-08-15 |
Novartis Pharma Ag |
Kombinationen von einem dpp-iv inhibitor und einem ppar- alpha agonist
|
|
US20040152720A1
(en)
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
|
UA83813C2
(ru)
|
2002-12-20 |
2008-08-26 |
Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг |
Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
|
|
DE602004019761D1
(de)
|
2003-01-08 |
2009-04-16 |
Novartis Vaccines & Diagnostic |
Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
DE10335027A1
(de)
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
JP2004250336A
(ja)
|
2003-02-18 |
2004-09-09 |
Kao Corp |
コーティング錠及び糖衣錠の製造法
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
|
MXPA05009564A
(es)
|
2003-03-12 |
2005-11-17 |
Univ Arizona |
Sales de bases debiles.
|
|
MXPA05009933A
(es)
|
2003-03-18 |
2005-11-04 |
Novartis Ag |
Composiciones que comprenden acidos grasos y aminoacidos.
|
|
CA2811272C
(en)
|
2003-04-08 |
2016-12-20 |
Progenics Pharmaceuticals, Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
JPWO2004096806A1
(ja)
|
2003-04-30 |
2006-07-13 |
大日本住友製薬株式会社 |
縮合イミダゾール誘導体
|
|
TW200510277A
(en)
|
2003-05-27 |
2005-03-16 |
Theravance Inc |
Crystalline form of β2-adrenergic receptor agonist
|
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2005000848A1
(en)
|
2003-06-20 |
2005-01-06 |
F. Hoffmann-La Roche Ag |
Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
|
|
ATE437876T1
(de)
|
2003-06-20 |
2009-08-15 |
Hoffmann La Roche |
Hexahydropyridoisochinoline als dpp-iv- inhibitoren
|
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
RS20060018A
(sr)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
|
|
US20050027012A1
(en)
|
2003-07-16 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Tablets containing ambroxol
|
|
CA2536111A1
(en)
|
2003-07-24 |
2005-02-03 |
Wockhardt Limited |
Oral compositions for treatment of diseases
|
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
JP2007501189A
(ja)
|
2003-08-01 |
2007-01-25 |
ジェネラブス テクノロジーズ，インコーポレイテッド |
フラビウイルス科に対する二環式イミダゾール誘導体
|
|
JP5653572B2
(ja)
|
2003-08-14 |
2015-01-14 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
第ｖｉｉ因子ポリペプチドの液状水性医薬組成物
|
|
CN102349927A
(zh)
|
2003-08-29 |
2012-02-15 |
Hdac默克研究有限责任公司 |
联合治疗癌症的方法
|
|
EP1699777B1
(en)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
EP1671649B1
(en)
|
2003-10-03 |
2011-11-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase IV inhibitors for treating diabetic patients with sulfonylurea secondary failure
|
|
BR0304443B1
(pt)
|
2003-10-28 |
2012-08-21 |
|
processo para obtenção de concentrados de titánio com elevado teor de tio2 e baixo teor de radionuclìdeos a partir de concentrados mecánicos de anatásio.
|
|
US7107714B2
(en)
|
2003-11-10 |
2006-09-19 |
Marketing Displays, Inc. |
Portable snap-fit sign stand
|
|
WO2005049022A2
(en)
|
2003-11-17 |
2005-06-02 |
Novartis Ag |
Use of dipeptidyl peptidase iv inhibitors
|
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US20070219178A1
(en)
|
2003-12-04 |
2007-09-20 |
Eisai Co., Ltd. |
Preventive or therapeutic agents for multiple sclerosis
|
|
US7217711B2
(en)
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
|
RU2381224C2
(ru)
|
2003-12-18 |
2010-02-10 |
Тиботек Фармасьютикалз Лтд. |
Пиперидинаминобензимидазольные производные как ингибиторы репликации респираторного синцитиального вируса
|
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
JP4994043B2
(ja)
|
2004-01-21 |
2012-08-08 |
エランコ・アニマル・ヘルス・アイルランド・リミテッド |
ミトラタピデ経口用溶液
|
|
SE0400234D0
(sv)
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New compounds, methods for their preparation and use thereof
|
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
|
EP1758905B1
(de)
|
2004-02-18 |
2009-04-29 |
Boehringer Ingelheim International GmbH |
8-[3-amino-piperidin-1-yl]-xanthine, deren herstellung und deren verwendung als dpp-iv hemmer
|
|
DE102004019540A1
(de)
|
2004-04-22 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
|
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
|
EP1593671A1
(en)
|
2004-03-05 |
2005-11-09 |
Graffinity Pharmaceuticals AG |
DPP-IV inhibitors
|
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
|
UA85871C2
(uk)
|
2004-03-15 |
2009-03-10 |
Такеда Фармасьютікал Компані Лімітед |
Інгібітори дипептидилпептидази
|
|
CN103030617A
(zh)
|
2004-03-16 |
2013-04-10 |
贝林格尔.英格海姆国际有限公司 |
吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
|
|
EP1577306A1
(de)
|
2004-03-17 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
|
|
US7179809B2
(en)
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
|
EP1740589A1
(de)
|
2004-04-10 |
2007-01-10 |
Boehringer Ingelheim International GmbH |
Neue 2-amino-imidazo[4,5-d]pyridazin-4-one und 2-amino-imidazo[4,5-c]pyridin-4-one, deren herstellung und deren verwendung als arzneimittel
|
|
US20050239778A1
(en)
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim International Gmbh |
Novel medicament combinations for the treatment of respiratory diseases
|
|
US20050244502A1
(en)
|
2004-04-28 |
2005-11-03 |
Mathias Neil R |
Composition for enhancing absorption of a drug and method
|
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
|
PL1753748T3
(pl)
|
2004-05-12 |
2010-01-29 |
Pfizer Prod Inc |
Pochodne proliny i ich zastosowanie jako inhibitorów peptydazy dipeptylowej IV
|
|
DE102004024454A1
(de)
|
2004-05-14 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
PE20060315A1
(es)
|
2004-05-24 |
2006-05-15 |
Irm Llc |
Compuestos de tiazol como moduladores de ppar
|
|
TWI415635B
(zh)
|
2004-05-28 |
2013-11-21 |
必治妥施貴寶公司 |
加衣錠片調製物及製備彼之方法
|
|
CA2567309A1
(en)
|
2004-06-01 |
2005-12-15 |
Ares Trading S.A. |
Method of stabilizing proteins
|
|
US7935723B2
(en)
|
2004-06-04 |
2011-05-03 |
Novartis Pharma Ag |
Use of organic compounds
|
|
US20050276794A1
(en)
|
2004-06-09 |
2005-12-15 |
Papas Klearchos K |
Composition and method for improving pancreatic islet cell survival
|
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
|
AU2005261778A1
(en)
|
2004-07-14 |
2006-01-19 |
Novartis Ag |
Combination of DPP-IV inhibitors and compounds modulating 5-HT3 and/or 5-HT4 receptors
|
|
JP2006045156A
(ja)
|
2004-08-06 |
2006-02-16 |
Sumitomo Pharmaceut Co Ltd |
縮合ピラゾール誘導体
|
|
TW200613275A
(en)
|
2004-08-24 |
2006-05-01 |
Recordati Ireland Ltd |
Lercanidipine salts
|
|
US20070259927A1
(en)
|
2004-08-26 |
2007-11-08 |
Takeda Pharmaceutical Company Limited |
Remedy for Diabetes
|
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
AU2005289881A1
(en)
|
2004-09-23 |
2006-04-06 |
Amgen Inc. |
Substituted sulfonamidopropionamides and methods of use
|
|
CN101035536A
(zh)
|
2004-10-08 |
2007-09-12 |
诺瓦提斯公司 |
有机化合物的组合
|
|
EP1799639B1
(en)
|
2004-10-12 |
2013-09-04 |
Glenmark Pharmaceuticals S.A. |
Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
|
|
AU2005299808B2
(en)
|
2004-10-25 |
2009-08-20 |
Novartis Ag |
Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin
|
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
|
DE102005013967A1
(de)
|
2004-11-05 |
2006-10-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
|
JP2006137678A
(ja)
|
2004-11-10 |
2006-06-01 |
Shionogi & Co Ltd |
インターロイキン−２組成物
|
|
CN101103032B
(zh)
|
2004-12-24 |
2011-05-11 |
大日本住友制药株式会社 |
双环吡咯衍生物
|
|
KR100760430B1
(ko)
|
2004-12-31 |
2007-10-04 |
한미약품 주식회사 |
당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
GT200600008A
(es)
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
|
US20090305964A1
(en)
|
2005-04-21 |
2009-12-10 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
|
KR20080000665A
(ko)
|
2005-04-22 |
2008-01-02 |
알란토스 파마슈티컬즈 홀딩, 인코포레이티드 |
디펩티딜 펩티다아제-ⅳ 억제제
|
|
US7898255B2
(en)
|
2005-04-25 |
2011-03-01 |
Hitachi, Ltd. |
Inspection apparatus using magnetic resonance and nuclear magnetic resonance signal receiver coil
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
CN101203494A
(zh)
|
2005-05-25 |
2008-06-18 |
惠氏公司 |
合成经取代3-氰基喹啉和其中间物的方法
|
|
JP5586829B2
(ja)
*
|
2005-06-03 |
2014-09-10 |
田辺三菱製薬株式会社 |
医薬の併用およびその用途
|
|
GT200600218A
(es)
|
2005-06-10 |
2007-03-28 |
|
Formulación y proceso de compresión directa
|
|
JP5301987B2
(ja)
|
2005-06-20 |
2013-09-25 |
デコード・ジェネティクス・イーエイチエフ |
２型糖尿病のリスクの診断マーカーとしてのｔｃｆ７ｌ２遺伝子中の遺伝子変異体
|
|
EP1904531B1
(en)
|
2005-07-08 |
2010-10-06 |
Pfizer Limited |
Madcam antibodies
|
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
CA2617715A1
(en)
|
2005-08-11 |
2007-02-15 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition comprising a dpp-iv inhibitor
|
|
EP1760076A1
(en)
|
2005-09-02 |
2007-03-07 |
Ferring B.V. |
FAP Inhibitors
|
|
PT1931350E
(pt)
|
2005-09-14 |
2014-02-12 |
Takeda Pharmaceutical |
Administração de inibidores de dipeptidil peptidase
|
|
MY147393A
(en)
|
2005-09-14 |
2012-11-30 |
Takeda Pharmaceutical |
Administration of dipeptidyl peptidase inhibitors
|
|
US20100160359A1
(en)
|
2005-09-16 |
2010-06-24 |
Arena Pharmaceuticals, Inc. |
Modulators of Metabolism and the Treatment of Disorders Related Thereto
|
|
EP1928499B1
(en)
|
2005-09-20 |
2011-06-29 |
Novartis AG |
Use of a dpp-iv inhibitor to reduce hypoglycemic events
|
|
WO2007038979A1
(en)
|
2005-09-22 |
2007-04-12 |
Swissco Development Ag |
Effervescent metformin composition and tablets and granules made therefrom
|
|
BRPI0616694B8
(pt)
|
2005-09-29 |
2021-05-25 |
Novartis Ag |
processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis
|
|
AU2006306420A1
(en)
|
2005-10-25 |
2007-05-03 |
Merck Sharp & Dohme Corp. |
Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
|
|
KR100945632B1
(ko)
|
2005-11-04 |
2010-03-04 |
엘에스전선 주식회사 |
수산화마그네슘 폴리머 하이브리드 입자의 제조방법
|
|
CA2633167A1
(en)
|
2005-12-16 |
2007-07-12 |
Merck & Co., Inc. |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
|
|
CA2633484A1
(en)
|
2005-12-23 |
2007-06-28 |
Novartis Ag |
Condensed heterocyclic compounds useful as dpp-iv inhibitors
|
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
|
JP2009522374A
(ja)
|
2006-01-06 |
2009-06-11 |
ノバルティス アクチエンゲゼルシャフト |
糖尿病処置のためのビルダグリプチンの使用
|
|
AR059489A1
(es)
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
WO2007099345A1
(en)
|
2006-03-02 |
2007-09-07 |
Betagenon Ab |
Medical use of bmp-2 and/ or bmp-4
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US8455435B2
(en)
*
|
2006-04-19 |
2013-06-04 |
Ludwig-Maximilians-Universitat Munchen |
Remedies for ischemia
|
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
|
EP2540725A1
(de)
|
2006-05-04 |
2013-01-02 |
Boehringer Ingelheim International GmbH |
Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
|
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
|
KR20070111099A
(ko)
|
2006-05-16 |
2007-11-21 |
영진약품공업주식회사 |
시타글립틴 염산염의 신규 결정형, 이의 제조 방법과 이를포함하는 약학적 조성물
|
|
SI2020996T1
(sl)
|
2006-05-16 |
2012-03-30 |
Gilead Sciences Inc |
Postopek in sestavki za zdravljenje hematološkihmalignosti
|
|
US20080064717A1
(en)
|
2006-05-19 |
2008-03-13 |
Rajesh Iyengar |
Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
|
|
KR100858848B1
(ko)
|
2006-05-23 |
2008-09-17 |
한올제약주식회사 |
메트포르민 서방정
|
|
WO2007149797A2
(en)
|
2006-06-19 |
2007-12-27 |
Novartis Ag |
Use of organic compounds
|
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
|
AT503443B1
(de)
|
2006-06-23 |
2007-10-15 |
Leopold Franzens Uni Innsbruck |
Verfahren zur herstellung einer eisfläche für eissportbahnen
|
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
JP2010500326A
(ja)
|
2006-08-08 |
2010-01-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糖尿病の治療のためのｄｐｐ−ｉｖ阻害剤としてのピロロ［３，２−ｄ］ピリミジン
|
|
WO2008020011A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
|
WO2008022267A2
(en)
|
2006-08-17 |
2008-02-21 |
Wellstat Therapeutics Corporation |
Combination treatment for metabolic disorders
|
|
DE102006042586B4
(de)
|
2006-09-11 |
2014-01-16 |
Betanie B.V. International Trading |
Verfahren zum mikropartikulären Beladen von hochpolymeren Kohlenhydraten mit hydrophoben Wirkflüssigkeiten
|
|
CA2668623A1
(en)
|
2006-11-06 |
2008-05-15 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
US7956201B2
(en)
|
2006-11-06 |
2011-06-07 |
Hoffman-La Roche Inc. |
Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one
|
|
AU2007316613B2
(en)
|
2006-11-09 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
|
|
JP5330260B2
(ja)
|
2006-12-06 |
2013-10-30 |
スミスクライン ビーチャム コーポレーション |
二環式化合物ならびに抗糖尿病薬としての使用
|
|
ES2319596B1
(es)
|
2006-12-22 |
2010-02-08 |
Laboratorios Almirall S.A. |
Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
|
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
|
PE20081849A1
(es)
|
2007-01-04 |
2009-01-26 |
Prosidion Ltd |
Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
|
|
CL2008000133A1
(es)
|
2007-01-19 |
2008-05-23 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un compuesto derivado de pirazol-o-glucosido combinado con al menos un segundo agente terapeutico; y uso de la composicion para el tratamiento de diabetes mellitus, cataratas, neuropatia, infarto de miocardio, e
|
|
AR065096A1
(es)
|
2007-02-01 |
2009-05-13 |
Takeda Pharmaceutical |
Preparacion solida
|
|
TWI453041B
(zh)
|
2007-02-01 |
2014-09-21 |
Takeda Pharmaceutical |
固體型製劑
|
|
JP5349332B2
(ja)
|
2007-02-06 |
2013-11-20 |
チェルシー・セラピューティクス，インコーポレイテッド |
新規化合物、その調製方法、およびその使用
|
|
JP2010521492A
(ja)
|
2007-03-15 |
2010-06-24 |
ネクティド，インク． |
徐放性ビグアニド組成物、および即時性ジペプチジルペプチダーゼｉｖ阻害剤組成物を含む抗糖尿病合剤
|
|
KR20120030570A
(ko)
|
2007-04-03 |
2012-03-28 |
미쓰비시 타나베 파마 코퍼레이션 |
디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용
|
|
JP5756289B2
(ja)
|
2007-04-16 |
2015-07-29 |
スミス アンド ネフュー インコーポレーテッドＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ，Ｉｎｃ． |
電動外科用システム
|
|
PE20090696A1
(es)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
Formas cristalinas de saxagliptina y procesos para preparar las mismas
|
|
US7910583B2
(en)
|
2007-05-04 |
2011-03-22 |
Bristol-Myers Squibb Company |
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
|
|
US8440172B2
(en)
|
2007-07-09 |
2013-05-14 |
Symrise Ag |
Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0
|
|
EA020870B1
(ru)
|
2007-07-19 |
2015-02-27 |
Такеда Фармасьютикал Компани Лимитед |
Твердый препарат, включающий алоглиптин и гидрохлорид метформина
|
|
CL2008002427A1
(es)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
|
|
CL2008002425A1
(es)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Composición farmacéutica que comprende un inhibidor de sglt2 y 1-(4-metil-quinazolin-2-il)metil-3metil-7-(-2-butin-1-il)-8-(3-(r)-amino-piperidin-1il)-xantina, un inhibidor de dpp iv y su uso para el tratamiento de la obesidad y de la diabetes tipo 1 y 2 y complicaciones de esta.
|
|
PE20090987A1
(es)
|
2007-08-16 |
2009-08-14 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un derivado de pirazol-o-glucosido
|
|
UY31291A1
(es)
|
2007-08-16 |
2009-03-31 |
|
Composicion farmacéutica que comprende un derivado de pirazol-0-glucosido
|
|
WO2009024542A2
(en)
|
2007-08-17 |
2009-02-26 |
Boehringer Ingelheim International Gmbh |
Purin derivatives for use in the treatment of fab-related diseases
|
|
US8338450B2
(en)
|
2007-09-21 |
2012-12-25 |
Lupin Limited |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
|
BRPI0820535B8
(pt)
|
2007-11-16 |
2021-05-25 |
Novo Nordisk As |
composições farmacêuticas contendo insulina e um peptídeo insulinotrópico
|
|
CN101234105A
(zh)
|
2008-01-09 |
2008-08-06 |
北京润德康医药技术有限公司 |
一种含有二甲双胍和维格列汀的药用组合物及其制备方法
|
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
|
US20090186086A1
(en)
|
2008-01-17 |
2009-07-23 |
Par Pharmaceutical, Inc. |
Solid multilayer oral dosage forms
|
|
TW200936136A
(en)
|
2008-01-28 |
2009-09-01 |
Sanofi Aventis |
Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
|
|
US20100330177A1
(en)
|
2008-02-05 |
2010-12-30 |
Merck Sharp & Dohme Corp. |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
|
|
US20100323011A1
(en)
|
2008-03-04 |
2010-12-23 |
Nazaneen Pourkavoos |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
|
|
BRPI0912245A2
(pt)
|
2008-03-05 |
2019-09-24 |
Takeda Pharmaceuticals Co |
composto, prodroga, medicamento, métodos de suprimir produção de açúcar em um mamífero e para a profilaxia ou o tratamento de diabetes em um mamífero, e, uso do composto
|
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
|
AU2009231906A1
(en)
|
2008-03-31 |
2009-10-08 |
Metabolex, Inc. |
Oxymethylene aryl compounds and uses thereof
|
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
PE20100156A1
(es)
|
2008-06-03 |
2010-02-23 |
Boehringer Ingelheim Int |
Tratamiento de nafld
|
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
|
NZ604091A
(en)
|
2008-08-15 |
2014-08-29 |
Boehringer Ingelheim Int |
Purin derivatives for use in the treatment of fab-related diseases
|
|
JP2010053576A
(ja)
|
2008-08-27 |
2010-03-11 |
Sumitomo Forestry Co Ltd |
舗装用マット
|
|
CN102149407A
(zh)
|
2008-09-10 |
2011-08-10 |
贝林格尔.英格海姆国际有限公司 |
治疗糖尿病和相关病症的组合疗法
|
|
UY32177A
(es)
|
2008-10-16 |
2010-05-31 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con control glucémico insuficiente a pesar de la terapia con fármaco, oral o no, antidiabético
|
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
|
CN102256976A
(zh)
*
|
2008-12-23 |
2011-11-23 |
贝林格尔.英格海姆国际有限公司 |
有机化合物的盐形式
|
|
AR074990A1
(es)
*
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
|
AR075204A1
(es)
|
2009-01-29 |
2011-03-16 |
Boehringer Ingelheim Int |
Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2
|
|
AU2010212823B2
(en)
|
2009-02-13 |
2016-01-28 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications comprising a DPP-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
|
|
JP5685550B2
(ja)
|
2009-02-13 |
2015-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
|
|
UY32427A
(es)
|
2009-02-13 |
2010-09-30 |
Boheringer Ingelheim Internat Gmbh |
Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
|
|
TW201031661A
(en)
|
2009-02-17 |
2010-09-01 |
Targacept Inc |
Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
|
US20120100221A1
(en)
|
2009-06-02 |
2012-04-26 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
|
|
EP2442806A1
(en)
|
2009-06-15 |
2012-04-25 |
Merck Sharp & Dohme Corp. |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
|
|
WO2011011541A1
(en)
|
2009-07-21 |
2011-01-27 |
Henry Trong Le |
Ferric citrate dosage forms
|
|
NZ598170A
(en)
|
2009-10-02 |
2014-06-27 |
Boehringer Ingelheim Int |
Pharmaceutical compositions comprising bi-1356 and metformin
|
|
UY32919A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
|
|
JP5446716B2
(ja)
|
2009-10-21 |
2014-03-19 |
大正製薬株式会社 |
アルギニン及びカルニチン含有錠剤の製造方法
|
|
KR20240090632A
(ko)
|
2009-11-27 |
2024-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
|
JP2010070576A
(ja)
|
2009-12-28 |
2010-04-02 |
Sato Pharmaceutical Co Ltd |
速溶解性錠剤
|
|
TWI562775B
(en)
|
2010-03-02 |
2016-12-21 |
Lexicon Pharmaceuticals Inc |
Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
|
|
EP2547339A1
(en)
|
2010-03-18 |
2013-01-23 |
Boehringer Ingelheim International GmbH |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
|
CN102946875A
(zh)
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
|
AR082091A1
(es)
|
2010-05-05 |
2012-11-14 |
Boehringer Ingelheim Int |
Composiciones farmaceuticas que comprenden pioglitazona y linagliptina y procedimiento de preparacion
|
|
WO2011154496A1
(en)
|
2010-06-09 |
2011-12-15 |
Poxel |
Treatment of type 1 diabetes
|
|
US8486453B2
(en)
|
2010-06-22 |
2013-07-16 |
Twi Pharmaceuticals, Inc. |
Controlled release compositions with reduced food effect
|
|
WO2011161161A1
(en)
|
2010-06-24 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Diabetes therapy
|
|
EP2611442B1
(en)
|
2010-09-03 |
2018-07-04 |
Bristol-Myers Squibb Company |
Drug formulations using water soluble antioxidants
|
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
|
WO2012088682A1
(en)
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
|
|
BR112013019026A2
(pt)
|
2011-02-01 |
2016-10-04 |
Astrazeneca Uk Ltd |
formulações farmacêuticas incluindo um composto amina
|
|
AR085689A1
(es)
|
2011-03-07 |
2013-10-23 |
Boehringer Ingelheim Int |
Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
|
|
CA2835332C
(en)
|
2011-05-10 |
2019-03-26 |
Sandoz Ag |
Polymorph of linagliptin benzoate
|
|
US8883800B2
(en)
|
2011-07-15 |
2014-11-11 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
|
US8849828B2
(en)
|
2011-09-30 |
2014-09-30 |
International Business Machines Corporation |
Refinement and calibration mechanism for improving classification of information assets
|
|
US20130172244A1
(en)
|
2011-12-29 |
2013-07-04 |
Thomas Klein |
Subcutaneous therapeutic use of dpp-4 inhibitor
|
|
WO2013103629A1
(en)
|
2012-01-04 |
2013-07-11 |
The Procter & Gamble Company |
Active containing fibrous structures with multiple regions
|
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
|
JP6224084B2
(ja)
|
2012-05-14 |
2017-11-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
|
|
JP6218811B2
(ja)
|
2012-05-14 |
2017-10-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
|
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
|
JP6374862B2
(ja)
|
2012-05-24 |
2018-08-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
自己免疫性糖尿病、特に、ｌａｄａの治療に使用するためのｄｐｐ−４阻害剤としてのキサンチン誘導体
|
|
WO2013174769A1
(en)
|
2012-05-25 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor
|
|
WO2013179307A2
(en)
|
2012-05-29 |
2013-12-05 |
Mylan Laboratories Limited |
Stabilized pharmaceutical compositions of saxagliptin
|
|
WO2014056941A1
(en)
|
2012-10-09 |
2014-04-17 |
Boehringer Ingelheim International Gmbh |
Use of moisture-conditioned disintegrants in tablet manufacture
|
|
JP2015533134A
(ja)
|
2012-10-09 |
2015-11-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
錠剤の機械的安定性に適切な少なくとも１種の水和物形成活性物質及び／又はアジュバントを含有する機械的に安定な錠剤、特にアルギニン含有錠剤の製造における選択的に水分調整された打錠材料の使用
|
|
US9050302B2
(en)
*
|
2013-03-01 |
2015-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
|
EP3744327A1
(en)
|
2013-03-15 |
2020-12-02 |
Boehringer Ingelheim International GmbH |
Use of linagliptin in cardio- and renoprotective antidiabetic therapy
|
|
EP4678242A3
(en)
|
2013-04-18 |
2026-03-18 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition, methods for treating and uses thereof
|
|
WO2014184376A1
(en)
|
2013-05-17 |
2014-11-20 |
Boehringer Ingelheim International Gmbh |
Combination of a dpp-4 inhibitor and an alpha-glucosidase inhibitor
|
|
EP3007701A1
(en)
|
2013-06-14 |
2016-04-20 |
Boehringer Ingelheim International GmbH |
Dpp-4 inhibitors for treating diabetes and its complications
|
|
EP3110449B1
(en)
*
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
|
WO2016059219A1
(en)
|
2014-10-17 |
2016-04-21 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
|
CN109310697A
(zh)
*
|
2016-06-10 |
2019-02-05 |
勃林格殷格翰国际有限公司 |
利格列汀和二甲双胍的组合
|